88.82USD+3.20%Mkt Cap: 51.14B $P/E: 52.871d ago
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap51.14B $
Enterprise Value46.59B $
Revenue (TTM)6.51B $
Gross Profit4.73B $
Net Income (TTM)1.07B $
Revenue/Share11.22 USD
Last Price88.82 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS28176E1082
Valuation
P/E (Trailing)52.87
P/E (Forward)25.50
PEG2.07
EV/EBITDA23.35
EV/Revenue7.15
P/S7.61
P/B4.81
EPS (TTM)1.68
EPS (Forward)3.38
52W Range
72.3069% of range96.29
52W High96.29 USD
52W Low72.30 USD
Profitability
Gross Margin78.01%
Oper. Margin29.84%
EBITDA Margin30.63%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth13.60%
Earnings Growth-25.40%
Cash Flow & Leverage
Operating CF1.60B $
CapEx (TTM)260.20M $
FCF Margin—
FCF Yield—
Net Debt-2.97B $
Net Debt/EBITDA-1.49
Balance Sheet
Debt/Equity0.07
Current Ratio—
Quick Ratio—
Book Value/Sh17.90 USD
Cash/Share6.376 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.96 USD
Upside (mean)+13.7%
Target Range84.00 USD – 110.00 USD
$84.00+13.7% to mean$110.00
# Analysts26
Ownership
Shares Out.575.80M
Float573.98M
Insiders0.18%
Institutions94.36%
Short Interest
Short Ratio2.3d
Short % Float2.24%
Short % Out.1.97%
Shares Short11.35M
Short (prev mo.)11.80M
Technical
SMA 5087.59 (+1.4%)
SMA 20083.68 (+6.1%)
Beta0.85
S&P 52W Chg18.32%
Avg Vol (30d)3.83M
Avg Vol (10d)5.70M
Technical Indicators
RSI (14)55.8
MACD-0.6947
MACD Signal-0.8005
MACD Hist.+0.1059
BB Upper94.87 USD
BB Middle87.47 USD
BB Lower80.07 USD
BB Width16.92%
ATR (14)2.534 USD
Vol Ratio (20d)0.72x